Tilray Brands, Inc. - Common Stock (TLRY)

Cannabis company Tilray Brands (NASDAQ:TLRY) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.7% year on year to $209.5 million. Its non-GAAP loss of $0 per share increased from -$0.04 in the same quarter last year.

Tilray Brands surged after posting stronger-than-expected quarterly results and renewed optimism around U.S. cannabis reform.

While the company regained Nasdaq compliance this quarter, its high float and low institutional ownership mean sentiment can swing fast.

Tilray Brands shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings report.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session.

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 24.9% in the morning session after the company reported third-quarter financial results that topped analyst expectations. 

Tilray surprised marijuana investors once today. Can it do it again?

Tilray stock surges after Q1 earnings beat estimates with break-even results, higher revenue, and improved balance sheet strength.

The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Cannabis company Tilray Brands (NASDAQ:TLRY) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $209.5 million. Its non-GAAP loss of $0 per share increased from -$0.04 in the same quarter last year.

Tilray Brands returns to profitability in Q1 fiscal 2026, posting record revenue and a positive EPS, driving a strong pre-market stock surge.

The company said that it reduced its total outstanding debt by $7.7 million in the three months in a bid to strengthen its balance sheet.

The potential for cannabis reform has made investors bullish on the industry in recent weeks.

Cannabis company Tilray Brands (NASDAQ:TLRY) will be reporting earnings this Thursday before the bell. Here’s what to look for.

The case for de facto marijuana legalization is growing, albeit slowly.

One marijuana industry insider says Monday's Truth Social video is a "trial balloon" testing support for marijuana legalization.

The cannabis market reacted big time to Trump's re-posting of a pro-CBD video that highlighted CBD’s potential to reduce aging-related ailments and replace costly pharmaceuticals. In addition, Tilray announced significant international expansion.